secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001493152-26-010526
Event type: litigation
Sentiment:  negative
Materiality: 0.85
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals files lawsuit seeking >$73M against Clarity Ventures; CEO options repriced to $0.45
--------------------------------------------------------------------------------

- Filed lawsuit in Texas state court against Clarity Ventures seeking damages exceeding $73M for failure to deliver HIPAA-compliant ERP/eCommerce platform.
- Clarity denies allegations and asserts counterclaims for unpaid invoices; company states all binding payments were made in full.
- CEO Jacob Cohen's options repriced: 50,000 at $16.50, 83,333 at $4.80, 2,000,000 at $2.30 → new exercise price $0.45 per share effective March 16, 2026.
- Company independently developed and deployed a new proprietary telehealth platform that does not rely on Clarity’s technology.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315226010526/0001493152-26-010526-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315226010526/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-010526

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer